Practice Guidelines provide practitioners with detailed information on complex conditions, and suggested evidence-based interventions for use in practice.
Description: Non-alcoholic fatty liver disease (NAFLD), encompassing both non-alcoholic fatty liver (NAFL) and non-alcoholic steatohepatitis (NASH), is the most common cause of liver disease in Australia. There is increasing evidence for considering NAFLD as part of metabolic syndrome including obesity, hyperinsulinaemia, insulin resistance, hypertriglyceridaemia and hypertension. Obesity is a clear risk factor for developing this common condition. The conventional therapeutic approach to NAFLD is based on lifestyle intervention, but there is no consensus on the ideal pharmacological treatment.